Medical Surveillance Program for NRC - Clinical Trial Material Facility - CTMF - Amendment 2

The National Research Council of Canada (NRC) appears to be seeking a medical surveillance program for its Clinical Trial Material Facility (CTMF) in Montreal, Quebec. The opportunity is currently listed as open and has a closing deadline of September 4, 2026, at 2:00 p.m. The notice identifies Amendment 2, which changes Mandatory Criterion M9. This amendment may affect whether a proposal is considered compliant, so bidders should review the amended requirement carefully along with the full request for proposals and the published questions and answers. The available documents include the original RFP, Amendment 2, an earlier amendment document, and the questions and answers. No separate official-source URL was provided here; verify the current tender notice, all amendments, submission instructions, mandatory criteria, and deadline on the official Canada Buys notice before submitting a bid. This opportunity potentially matches Canadian businesses that can deliver the required medical surveillance services, but the tender documents must be reviewed to determine suitability and compliance.

• check_circleThe tender is open and closes on September 4, 2026 at 2:00 p.m.; the applicable time zone is not stated in the provided tender text and should be verified in the official notice.
• check_circleThe requirement concerns a Medical Surveillance Program for the NRC Clinical Trial Material Facility (CTMF) in Montreal, Quebec.
• check_circleThe buyer is the National Research Council of Canada (NRC).
• check_circleAmendment 2 changes Mandatory Criterion M9. The amended M9 requirement must be reviewed in the attached amendment and applicable request-for-proposal documents before preparing a bid.